| Product Code: ETC9733719 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Togo continued to rely on imports of non-steroidal anti-inflammatory drugs, with top exporting countries being Metropolitan France, India, China, United States of America, and Denmark. Despite the low concentration of the Herfindahl-Hirschman Index (HHI), indicating a diverse import market, specific growth rates and CAGR data were not available for this period. Togo`s dependence on imports from multiple countries underscores the importance of ensuring a stable and diversified supply chain for essential pharmaceutical products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Togo Non-steroidal Anti-inflammatory Drugs Market Overview |
3.1 Togo Country Macro Economic Indicators |
3.2 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, 2022 & 2032F |
3.3 Togo Non-steroidal Anti-inflammatory Drugs Market - Industry Life Cycle |
3.4 Togo Non-steroidal Anti-inflammatory Drugs Market - Porter's Five Forces |
3.5 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.6 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Disease Indication, 2022 & 2032F |
3.7 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Togo Non-steroidal Anti-inflammatory Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of musculoskeletal disorders and inflammatory conditions in Togo |
4.2.2 Growing geriatric population, who are more prone to conditions that require non-steroidal anti-inflammatory drugs (NSAIDs) |
4.2.3 Rising awareness and adoption of NSAIDs as a primary treatment option for pain management |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and sale of NSAIDs in Togo |
4.3.2 Adverse side effects associated with long-term use of NSAIDs, leading to concerns among healthcare providers and patients |
5 Togo Non-steroidal Anti-inflammatory Drugs Market Trends |
6 Togo Non-steroidal Anti-inflammatory Drugs Market, By Types |
6.1 Togo Non-steroidal Anti-inflammatory Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Route of Administration, 2022 - 2032F |
6.1.3 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Oral, 2022 - 2032F |
6.1.4 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Parenteral, 2022 - 2032F |
6.1.5 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Topical, 2022 - 2032F |
6.2 Togo Non-steroidal Anti-inflammatory Drugs Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Arthritis, 2022 - 2032F |
6.2.3 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Migraine, 2022 - 2032F |
6.2.4 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Ophthalmic Diseases, 2022 - 2032F |
6.2.5 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Togo Non-steroidal Anti-inflammatory Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
6.3.3 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
6.3.4 Togo Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Online Pharmacy, 2022 - 2032F |
7 Togo Non-steroidal Anti-inflammatory Drugs Market Import-Export Trade Statistics |
7.1 Togo Non-steroidal Anti-inflammatory Drugs Market Export to Major Countries |
7.2 Togo Non-steroidal Anti-inflammatory Drugs Market Imports from Major Countries |
8 Togo Non-steroidal Anti-inflammatory Drugs Market Key Performance Indicators |
8.1 Prescription rates of NSAIDs by healthcare practitioners in Togo |
8.2 Number of clinical trials and research studies focusing on the efficacy and safety of NSAIDs in the Togolese population |
8.3 Patient satisfaction and reported outcomes after NSAID treatment |
9 Togo Non-steroidal Anti-inflammatory Drugs Market - Opportunity Assessment |
9.1 Togo Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.2 Togo Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Disease Indication, 2022 & 2032F |
9.3 Togo Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Togo Non-steroidal Anti-inflammatory Drugs Market - Competitive Landscape |
10.1 Togo Non-steroidal Anti-inflammatory Drugs Market Revenue Share, By Companies, 2025 |
10.2 Togo Non-steroidal Anti-inflammatory Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here